Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
1,020.35
1,041.00
1,030.10
1,088.59
778.90
1,615.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,020.35
1,041.00
1,030.10
1,088.59
778.90
1,615.50
Raw Material Cost
782.43
811.56
803.68
834.52
602.70
882.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
173.96
0.00
153.46
148.31
120.55
131.01
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.35
0.21
0.85
1.91
0.94
12.36
Selling and Distribution Expenses
65.90
58.13
56.60
68.56
43.20
88.65
Other Expenses
-13.68
3.83
-11.98
-11.70
-9.50
-9.49
Total Expenditure (Excl Depreciation)
886.82
908.19
894.79
936.34
672.44
1,019.38
Operating Profit (PBDIT) excl Other Income
133.5
132.79999999999998
135.29999999999998
152.20000000000002
106.5
596.1
Other Income
9.59
17.26
17.59
37.36
49.77
-11.11
Operating Profit (PBDIT)
178.34
182.74
149.84
185.07
155.81
583.00
Interest
1.35
0.21
0.85
1.91
0.94
12.36
Exceptional Items
0.07
0.01
-0.25
0.00
0.05
-37.15
Gross Profit (PBDT)
237.92
229.44
226.41
254.07
176.20
733.26
Depreciation
50.68
44.84
6.12
5.33
5.29
6.59
Profit Before Tax
126.38
137.69
142.62
177.83
149.63
526.90
Tax
14.94
17.48
19.08
20.49
18.00
142.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
111.44
120.22
123.55
157.34
131.63
384.26
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
111.44
120.22
123.55
157.34
131.63
384.26
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
111.44
120.22
123.55
157.34
131.63
384.26
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,494.46
1,420.14
909.35
783.29
617.04
476.90
Earnings per share (EPS)
0.71
0.77
0.79
1.01
0.84
2.46
Diluted Earnings per share
0.71
0.77
0.79
1.01
0.84
2.46
Operating Profit Margin (Excl OI)
11.57%
11.59%
12.25%
13.08%
12.94%
36.37%
Gross Profit Margin
17.35%
17.53%
14.44%
16.83%
19.89%
33.02%
PAT Margin
10.92%
11.55%
11.99%
14.45%
16.9%
23.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -1.98% vs 1.06% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -7.32% vs -2.67% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 1.99% vs 25.09% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 600.00% vs -77.78% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Jianerkang Medical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,020.35
0
1,020.35
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,020.35
0
1,020.35
Raw Material Cost
782.43
0
782.43
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
173.96
0
173.96
Power Cost
0
0
0.00
Manufacturing Expenses
1.35
0
1.35
Selling and Distribution Expenses
65.90
0
65.90
Other Expenses
-13.68
0.00
-13.68
Total Expenditure (Excl Depreciation)
886.82
0
886.82
Operating Profit (PBDIT) excl Other Income
133.53
0.00
133.53
Other Income
9.59
0
9.59
Operating Profit (PBDIT)
178.34
0
178.34
Interest
1.35
0
1.35
Exceptional Items
0.07
0
0.07
Gross Profit (PBDT)
237.92
0
237.92
Depreciation
50.68
0
50.68
Profit Before Tax
126.38
0
126.38
Tax
14.94
0
14.94
Provisions and contingencies
0
0
0.00
Profit After Tax
111.44
0
111.44
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
111.44
0
111.44
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
111.44
0
111.44
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,494.46
0
1,494.46
Earnings per share (EPS)
0.71
0
0.71
Diluted Earnings per share
0.71
0
0.71
Operating Profit Margin (Excl OI)
11.57%
0%
0.00
11.57%
Gross Profit Margin
17.35%
0%
0.00
17.35%
PAT Margin
10.92%
0%
0.00
10.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 102.04 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.98% vs 1.06% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 11.14 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -7.32% vs -2.67% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.99% vs 25.09% in Dec 2024
Annual - Interest
Interest 0.14 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 600.00% vs -77.78% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.57%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






